Mass COVID-19 vaccinations begin in Israel: 240 test positive for coronavirus after vaccination

 

 

Israel approved the Pfizer-BioNTech vaccine and began mass vaccinations on December 20, 2020. The Prime Minister Netanyahu and the President Rivlin were the first to be inoculated, followed by medical workers, medical school students, workers at care facilities for the elderly and government officials.

 

Channel 13 News reported that 240 of those who were vaccinated developed COVID-19. The Pfizer vaccine takes time to develop antibodies and has to be taken as two doses, 21 days apart so there is a possibility of developing coronavirus in the interim period. It is also possible that if someone was already infected, they could develop COVID symptoms after the inoculation.

 

Some other concerns are that people who have immunity could possibly infect others and spread the virus as there is much to be learnt about the virus: the ways in which it mutates, the vaccine itself and individual responses to the vaccine which may vary due to several known and unknown factors.

 

As per government data, most of the people had no side effects though some reported weakness, dizziness, fever, and diarrhea. Some individuals have had allergic and neurological reactions to the vaccine. Four deaths occurred after the vaccination, three of which were not related to the inoculation and the fourth is under investigation.

 

On January 1, government authorities said that one million people which is  over 10% of its population, were vaccinated. The government has also ordered vaccines from Moderna, another major Pharma giant who has a similar vaccine.

 

The Jerusalem-based Hadassah Medical Center has also entered into an agreement to purchase 1.5 million doses of the Sputnik V vaccine manufactured by Russia. The Health Ministry has not as yet approved this vaccine.


Follow us on Google news for more updates and News










PLEASE READ THE IMPORTANT DISCLOSURES BELOW.

This content is being provided to you for informational purposes only. The content has been prepared by third parties not affiliated with CWEB Inc, a business. This content and any information contained therein, does not constitute a recommendation by CWEB to buy, sell or hold any security, financial product or instrument referenced in the content. This information neither is, nor should be construed as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. CWEB Inc. does not offer or provide any opinion regarding the nature, potential, value, suitability or profitability of any particular investment or investment strategy, and you shall be fully responsible for any investment decisions you make, and such decisions will be based solely on your evaluation of your financial circumstances, investment objectives, risk tolerance, and liquidity needs.

Unless stated otherwise, the web content provided by the CWEB family of companies is for educational purposes only. The information and tools provided neither are, nor should be construed, as an offer, or a solicitation of an offer, to buy or sell securities by CWEB Inc. or its affiliates. Unless stated otherwise, no information presented constitutes a recommendation by CWEB Inc. or its affiliates to buy, sell or hold any security, financial product or instrument discussed therein or to engage in any specific investment strategy.

Full Disclaimer

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.